Cnicin
Based on 1 Customer Validation
Cnicin is an orally bioavailable sesquiterpene lactone. Cnicin has antibacterial and antiproliferative properties and induces apoptosis in primary myeloma cells. Cnicin also exhibits activity against SARS-CoV-2. Cnicin inhibits the viral replication of SARS CoV-2 with an IC50 of 1.18 μg/mL. Cnicin can promote functional nerve regeneration.
For research use only. We do not sell to patients.
- Purity: 99.14%
- CAS No.: 24394-09-0
- Formula: C20H26O7
- Molecular Weight:378.42
-
Storage:
-20°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
Biological Activity
Cnicin (0-10 μM, 72 h) inhibits the proliferation of multiple myeloma cells, with an IC50 of 3-13 μM, and induces apoptosis[1].
Cnicin (2 μM, 0-12 h) induces cell death, partly depending on caspase[1].
Cnicin (0.5-5 nM, 4 days) has significant effects on promoting nerve regeneration[3].
Cnicin demonstrates strong inhibitory activity on NF-κB, SP-1, and iNOS in PMA (HY-18739) induced SW1353 cells, with IC50 values of 1.8, 16, and 6.5 µM[4].
Cnicin (50 μg) has a zone of inhibition for Gram-positive bacteria ranging from 14-17 mm, and for Gram-negative bacteria, it ranges from 10-20 mm[5].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:LP-1, NCI, OPM-2, RPMI, U266, MM1.S
-
Concentration:0, 2, 4, 6, 8, 10 μM
-
Incubation Time:72 h
-
Result:Inhibited cell proliferation.
-
Cell Line:NCI-H929
-
Concentration:2 μM
-
Incubation Time:0, 3, 6, 9, 12 h
-
Result:Induced the activation of Caspase, downregulation of Caspase 3, cleavage of Caspase 3 and cleaved Caspases 8 and 9.
Pharmacokinetic parameters of a single intravenous or oral administration of 0.8 mg Cnicin in rats[3]
| Parameters | Estimate | RES (%) |
| Ka (1/min) | 0.0321 | 18.4 |
| CL (1/min) | 0.00101 | 10.7 |
| VC (l) | 0.00745 | 8.9 |
| F1 (%) | 0.847 | 14.6 |
| Qp (1/min) | 0.00298 | 5.0 |
| Vp (l) | 0.00985 | 12.5 |
| Lag time (min) | 5.02 | 13.6 |
| CL (%) | 17.2 (13.0) | 31.6 |
| Vc (%) | 29.0 (32.0) | 27.8 |
| Additive error (%) | 4.76 (6.4) | 12.1 |